Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Dainippon Sumitomo Pharma reaches agreement on acquisition

March 1, 2012

New protein kinase inhibitors identified at Nerviano Medical Sciences

March 1, 2012

Merck KGaA reports new P70S6K inhibitors

March 1, 2012

Novel ALK inhibitors created with anticancer potential

March 1, 2012

OncoSec initiates treatment in phase II trial in metastatic melanoma

Feb. 29, 2012

Phase III trials of 6-month anticancer depot begin in Japan

Feb. 29, 2012

Medexis reports new products with potential to treat cancer

Feb. 29, 2012

New cyclopropylamine derivatives designed at Oryzon Genomics

Feb. 29, 2012

Phase II trial assesses safety paclitaxel/everolimus combination in advanced urothelial cancer

Feb. 29, 2012

Apeiron begins study in prevention of radiation dermatitis

Feb. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...